세계의 바실러스 코아귤런스 시장 규모는 2023년에는 9,183만 달러로 평가되었습니다. 2024년 9,927만 달러에서 2032년에는 1억 8,510만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 8.1%를 나타낼 전망입니다.
유산균과 유사한 유익균인 바실러스 코아귤란스의 글로벌 시장은 건강에 대한 인식이 높아지고 기능성 식품에 대한 수요가 급증함에 따라 크게 성장하고 있습니다. 치료 용도로 알려진 바실러스 코아귤런스는 로타바이러스와 같은 감염으로 인한 설사뿐만 아니라 과민성 대장 증후군, 염증성 장 질환(IBD), 호흡기 감염과 같은 질환을 포함한 다양한 유형의 설사를 치료하는 데 효과적입니다. 또한 면역계를 강화하는 역할도 있고 다른 이점도 있습니다. 그러나 시장의 잠재력은 그 효능에 관하여 소비자에게 널리 알려지지 않은 것이 다소 방해 요인으로 작용합니다. 그럼에도 불구하고 신흥 경제 국가에서 R & D의 확대와 핵심 균류 제품에 대한 관심 증가는 미래 성장 기회로 유망합니다.
Global Bacillus Coagulans Market size was valued at USD 91.83 million in 2023 and is poised to grow from USD 99.27 million in 2024 to USD 185.1 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
The global market for Bacillus coagulans, a beneficial bacterium akin to lactobacillus, is witnessing significant growth driven by heightened health awareness and a surge in demand for functional foods. Known for its therapeutic applications, Bacillus coagulans is effective in treating various types of diarrhea, including those caused by infections like rotavirus, as well as conditions such as IBS, inflammatory bowel diseases (IBD), and respiratory infections. Furthermore, its role in bolstering the immune system presents additional health benefits. However, the market's potential is somewhat hindered by widespread consumer unawareness regarding its effectiveness. Nonetheless, the expansion of research and development and increased interest in Bacillus coagulans products in emerging economies presents promising opportunities for future growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bacillus Coagulans market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bacillus Coagulans Market Segmental Analysis
Global Bacillus Coagulans Market is segmented by Type, Sources, Application, End-Users and region. Based on Type, the market is segmented into Type1, Type2 and Type3. Based on Sources, the market is segmented into Natural Source, Plants, Animals, Clinical Sources and Others. Based on Application, the market is segmented into Non-Dairy, Dairy, Cereal, Drugs, Infant Nutrition and Others. Based on End-Users, the market is segmented into Food and Beverages, Cosmeceutical Industries, Nutraceutical Manufacturers, Pharmaceutical Manufacturers, Animal Husbandry and Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Bacillus Coagulans Market
The global Bacillus Coagulans market is primarily driven by its significant benefits in addressing acne and various skin conditions, leading to an increased demand within the cosmetics industry. Cosmetic manufacturers are formulating innovative products infused with Bacillus Coagulans, highlighting its anti-aging properties across a wide range of items, including face masks, lotions, scrubs, gels, creams, and cleansers. Additionally, there is a growing trend towards the incorporation of Bacillus Coagulans as a cosmeceutical component in diverse cosmetic products, such as creams and powders. Its effectiveness in managing conditions like atopic dermatitis and eczema further elevates its use in moisturizers and anti-acne treatments, solidifying its role as a crucial ingredient in personal care formulations.
Restraints in the Global Bacillus Coagulans Market
The global Bacillus coagulans market faces certain constraints primarily related to safety concerns and side effects associated with its use. While generally considered safe, indiscriminate dosing can lead to gastrointestinal issues such as gas and bloating. The lack of familiarity with Bacillus coagulans in the human digestive system raises ongoing debates regarding its potential risks and adverse effects. Additionally, some identified strains are not suitable for probiotic applications, and the existing research on these probiotics remains limited. Furthermore, there is apprehension that Bacillus coagulans spores could potentially escape the digestive tract and affect other organs, posing risks for immunocompromised individuals or those with catheters, as this could lead to bacterial infections.
Market Trends of the Global Bacillus Coagulans Market
The Global Bacillus Coagulans market is witnessing significant growth, driven by a rising consumer shift towards health-conscious dietary choices, particularly in dairy-free and vegan segments. This trend is largely fueled by increasing lactose intolerance, milk protein allergies, and a burgeoning vegan population, leading to a heightened demand for non-dairy probiotics. Bacillus coagulans has emerged as a preferred ingredient due to its recognized safety by regulatory bodies like the FDA and EFSA, making its way into functional foods and supplements. Furthermore, its impressive stability during processing enhances its appeal, while affordability positions it as a viable alternative to potentially harmful chemicals in the food industry.